It is recognized that both genetic and environmental factors play a role in breast cancer. The genetic component has been verified by the discovery of the high-penetrance genes BRCA1 and BRCA2. Hormonal factors, radiation, diet, oral contraceptive use and estrogen replacement therapy are among some of environmental factors believed to influence breast cancer risk. Population genetic theory predicts that a large proportion of the prevalence of complex diseases will be due to genetic variation and environmental risk factors that are common in the population. Low penetrance genetic variants may not have a large influence on individual risk, however when common in the population, will be a large component of the overall attributable risk for the disease. Until recently, the interaction between environmental risk factors and genes in determining breast cancer risk has not been explored. We are now at a point where we can use the existing resource of population-based breast cancer families to characterize common genetic variants in a series of candidate breast cancer modifier genes and study the relationship between this variation, environmental risk factors and breast cancer risk. This innovative approach uses our fully characterized resource.
The Specific Aims of this new phase are as follows: 1) We will, in an initial discovery phase, identify common sequence variants in a panel of candidate genes selected because of their potential function in a specific pathway known to be associated with increased risk of breast cancer or physiological changes associated with a known risk factor for breast cancer; 2) To study the relationship between a series of candidate genes and breast cancer risk; 3) To study the effects on breast cancer risk due to the environmental risk factors and the interaction between the candidate genes and environmental risk factors; 4) To validate and fine map any genetic factors which are found to influence breast cancer risk in the analyses described in Specific Aims 2 and 3.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058860-12
Application #
7072753
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Mikhail, Isis S
Project Start
1994-02-04
Project End
2009-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
12
Fiscal Year
2006
Total Cost
$609,091
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Earp, Madalene; Tyrer, Jonathan P; Winham, Stacey J et al. (2018) Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One 13:e0197561
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Carpenter, Philip M; Ziogas, Argyrios; Markham, Emma M et al. (2018) Laminin 332 expression and prognosis in breast cancer. Hum Pathol 82:289-296
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Kar, Siddhartha P; Adler, Emily; Tyrer, Jonathan et al. (2017) Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer 116:524-535
Rasmussen, Christina B; Kjaer, Susanne K; Albieri, Vanna et al. (2017) Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. Am J Epidemiol 185:8-20
Dixon, Suzanne C; Nagle, Christina M; Wentzensen, Nicolas et al. (2017) Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer 116:1223-1228

Showing the most recent 10 out of 113 publications